MedPath

The role of the Anal Fistula Plug combined with infliximab in the treatment of perianal fistula due to Crohn*s disease. -a randomised controlled trial

Conditions
anorectal fistula
perianal fistula
10002112
10017998
Registration Number
NL-OMON29741
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Crohn*s disease
Infliximab treatment and chronic loose seton drainage > 2 months
High anorectal fistula (transsfincteric, upper 2/3 of the sfinctercomplex which is confined by the puborectal sling and the end of the anal canal)
Informed consent

Exclusion Criteria

Cryptoglandular fistula
Age<18 years
HIV-positive
No internal opening found during surgery
Perianal abscesses on preoperative MRI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Anorectal fistula closure rate<br /><br><br /><br>2. Continence</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Morbidity<br /><br><br /><br>2. Quality of life</p><br>
© Copyright 2025. All Rights Reserved by MedPath